Inflammatory bowel disease diagnosed before age 6 years can be distinguished from older onset pediatric and adult IBD by its unique phenotype of severe morbidity, poor response to conventional therapies, greater duration of disease, and its rapidly increasing prevalence. This population is further divided into those diagnosed <2 year of age, infantile IBD, and children diagnosed between 2 and 6 years old, whom we refer to as early childhood IBD for this proposal. While pediatric IBD is a complex polygenic disease, we and others have identified causative monogenic defects in infantile IBD. However, little is understood about the pathogenic mechanisms in early childhood IBD. The underlying hypothesis of this proposal is that patients with early childhood IBD have a unique host genomic background coupled with early life exposures. This interaction leads to a dysfunctional dynamic between the immune response and the intestinal microbial community structure. The PI will utilize this career development and research plan in order to gain skills and establish collaborations which will allow her to develop future translational studies leveraging large data sets to identify future therapeutic targets to improve treatment outcomes for early childhood-IBD. Using cutting edge technology, we will generate genomic and microbiome data to study children with early childhood IBD.
In Aim 1, the PI will identify the role of both rare and low frequency variants using whole exome sequencing and calculate the polygenic risk score based on known IBD susceptibility loci in order to characterize the genetic burden of the early childhood IBD phenotype.
In Aim 2, stool samples will be collected during the first 8 weeks of initiating IBD treatment in 100 newly diagnosed early childhood IBD patients in addition to collecting data regarding environmental exposures. Shotgun metagenomic sequencing will be used to discern the microbial community structure at each time point. The baseline microbiota will be correlated with early life environmental exposures and the longitudinal microbiota will be analyzed in the context of changing disease activity. As part of her career development plan, this research plan with allow the PI to refine and acquire skills with the support of her mentors, receive hands on training from her collaborators, enroll in formal coursework, and participate in multidisciplinary seminars and conferences to prepare her for a future career as an independent investigator.
Children with inflammatory bowel disease diagnosed between age 2 and 6 years have a severe, chronic disorder, often refractory to conventional therapy and whose incidence is rapidly increasing. The use of advanced technology in this research proposal will allow for improved understanding of the genomic and microbial contributions of IBD in this age group in order to identify more precise targets for therapies and improve these children?s quality of life.
